These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 33383186)
1. Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome. Matagne V; Borloz E; Ehinger Y; Saidi L; Villard L; Roux JC Neurobiol Dis; 2021 Feb; 149():105235. PubMed ID: 33383186 [TBL] [Abstract][Full Text] [Related]
2. A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome. Matagne V; Ehinger Y; Saidi L; Borges-Correia A; Barkats M; Bartoli M; Villard L; Roux JC Neurobiol Dis; 2017 Mar; 99():1-11. PubMed ID: 27974239 [TBL] [Abstract][Full Text] [Related]
3. Recent endeavors in MECP2 gene transfer for gene therapy of Rett syndrome. Sinnett SE; Gray SJ Discov Med; 2017 Oct; 24(132):153-159. PubMed ID: 29272692 [TBL] [Abstract][Full Text] [Related]
4. Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin. Villani C; Sacchetti G; Carli M; Invernizzi RW Neuropharmacology; 2020 Oct; 176():108221. PubMed ID: 32652084 [TBL] [Abstract][Full Text] [Related]
5. A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome. Schmid DA; Yang T; Ogier M; Adams I; Mirakhur Y; Wang Q; Massa SM; Longo FM; Katz DM J Neurosci; 2012 Feb; 32(5):1803-10. PubMed ID: 22302819 [TBL] [Abstract][Full Text] [Related]
6. Activation of the Medial Prefrontal Cortex Reverses Cognitive and Respiratory Symptoms in a Mouse Model of Rett Syndrome. Howell CJ; Sceniak MP; Lang M; Krakowiecki W; Abouelsoud FE; Lad SU; Yu H; Katz DM eNeuro; 2017; 4(6):. PubMed ID: 29333487 [TBL] [Abstract][Full Text] [Related]
7. Cell-Genotype Specific Effects of Mecp2 Mutation on Spontaneous and Nicotinic Acetylcholine Receptor-Evoked Currents in Medial Prefrontal Cortical Pyramidal Neurons in Female Rett Model Mice. Asgarihafshejani A; Nashmi R; Delaney KR Neuroscience; 2019 Aug; 414():141-153. PubMed ID: 31299345 [TBL] [Abstract][Full Text] [Related]
8. Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice. Gadalla KK; Bailey ME; Spike RC; Ross PD; Woodard KT; Kalburgi SN; Bachaboina L; Deng JV; West AE; Samulski RJ; Gray SJ; Cobb SR Mol Ther; 2013 Jan; 21(1):18-30. PubMed ID: 23011033 [TBL] [Abstract][Full Text] [Related]
9. Protective role of mirtazapine in adult female Mecp2 Flores Gutiérrez J; De Felice C; Natali G; Leoncini S; Signorini C; Hayek J; Tongiorgi E J Neurodev Disord; 2020 Sep; 12(1):26. PubMed ID: 32988385 [TBL] [Abstract][Full Text] [Related]
11. Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model. Vermudez SAD; Gogliotti RG; Arthur B; Buch A; Morales C; Moxley Y; Rajpal H; Conn PJ; Niswender CM Genes Brain Behav; 2022 Jan; 21(1):e12752. PubMed ID: 34002468 [TBL] [Abstract][Full Text] [Related]
12. Fluoxetine increases brain MeCP2 immuno-positive cells in a female Mecp2 heterozygous mouse model of Rett syndrome through endogenous serotonin. Villani C; Carli M; Castaldo AM; Sacchetti G; Invernizzi RW Sci Rep; 2021 Jul; 11(1):14690. PubMed ID: 34282222 [TBL] [Abstract][Full Text] [Related]
13. Wild-type MECP2 expression coincides with age-dependent sensory phenotypes in a female mouse model for Rett syndrome. Mykins M; Layo-Carris D; Dunn LR; Skinner DW; McBryar AH; Perez S; Shultz TR; Willems A; Lau BYB; Hong T; Krishnan K J Neurosci Res; 2023 Aug; 101(8):1236-1258. PubMed ID: 37026482 [TBL] [Abstract][Full Text] [Related]
15. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation. Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of genetic MECP2 supplementation in the R294X mouse model of Rett syndrome. Collins BE; Merritt JK; Erickson KR; Neul JL Genes Brain Behav; 2022 Jan; 21(1):e12739. PubMed ID: 33942492 [TBL] [Abstract][Full Text] [Related]
17. MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder. Liao W; Gandal MJ; Ehrlichman RS; Siegel SJ; Carlson GC Neurobiol Dis; 2012 Apr; 46(1):88-92. PubMed ID: 22249109 [TBL] [Abstract][Full Text] [Related]
18. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome. Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047 [TBL] [Abstract][Full Text] [Related]
19. The Efficacy of a Human-Ready mini Sadhu C; Lyons C; Oh J; Jagadeeswaran I; Gray SJ; Sinnett SE Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254921 [TBL] [Abstract][Full Text] [Related]
20. Breathing abnormalities in a female mouse model of Rett syndrome. Johnson CM; Cui N; Zhong W; Oginsky MF; Jiang C J Physiol Sci; 2015 Sep; 65(5):451-9. PubMed ID: 26071253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]